A carregar...
TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma
In the past decades, chemotherapy has resulted in improved outcomes for patients with osteosarcoma. However, resistance to chemotherapy often leads to poor prognoses. Cisplatin is a standard drug for osteosarcoma therapy, and chemoresistance to cisplatin in osteosarcoma limits the effectiveness of c...
Na minha lista:
| Publicado no: | Int J Mol Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6108886/ https://ncbi.nlm.nih.gov/pubmed/30015899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2018.3753 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|